Fevipiprant, a Selective Prostaglandin D(2)Receptor 2 Antagonist, Potently Inhibits Chemotaxis and Cytokine Production by Tc2 cells (type-2 CD8(+)lymphocytes)
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要